NEW SURGICAL MANAGEMENT OF BPH: HOLEP
- VernacularTitle:ТҮРҮҮ БУЛЧИРХАЙН ХОРГҮЙ ТОМРОЛЫН ШИНЭ МЭС ЗАСАЛ ЭМЧИЛГЭЭ: HOLEP
- Author:
Liu Suo
;
Munkhbayarlakh S
;
Ankhbold G
;
Iderchimeg D
;
Shiirevnyamba A
- Collective Name:Mongolian National University of Medical Sciences, School of Medicine
- Publication Type:Journal Article
- Keywords:
HoLEP;
benign prostatic hyperplasia;
transurethral resection of prostate
- From:Journal of Surgery
2016;19(1):77-
- CountryMongolia
- Language:Mongolian
-
Abstract:
Introduction: Transurethral resection of
the prostate (TURP) has been considered as
the gold standard treatment for obstructive
voiding dysfunction in men with benign
prostatic hyperplasia. This standard treatment
has been challenged by consistent data
demonstrating the superiority of Holmium
enucleation of the prostate (HoLEP). We
review summarizes the literature comparing
HoLEP to traditional therapies TURP, open
prostatectomy (OP) for BPH these are widely
used and have long term efficacy data.
Patients undergoing HoLEP have significant
shortened catheterization times, decreased
length of hospital stay, fewer serious postoperative
complications, greater reduction in
post-operative IPSS, greater improvements
in post-operative Qmax and lower rates of
repeat endoscopic procedures for recurrent
symptoms compared with TURP and OP.
Furthermore, HoLEP can be used to resect
more than 100 grams tissue and it is
equivalent efficacy to open prostatectomy.
Conclusion: HoLEP as the new gold
standard treatment for surgical BPH therapy
further. HoLEP remains its difficult learning
curve when compared with traditional
transurethral resection.
- Full text:W020170329580426324931.pdf
